HARVARD BIOSCIENCE INC — Director's Dealing 2022

May 26, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2022-05-24

Reporting Person: Loewald Thomas W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-24	Common Stock	A	38259	$0.00	Acquired	223885	Direct

Footnotes

F1: Represents an award of 38,259 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2022, immediately prior to the commencement of such meeting, and (ii) May 24, 2023.

F2: Includes (a) the award described in footnote (1) above and (b) 185,626 shares of common stock held by the Reporting Person.